N-acetylglucosamine (GlcNAc-inducible gene GIG2 is a novel component of GlcNAc metabolism in Candida albicans by Ghosh, Swagata et al.
N-Acetylglucosamine (GlcNAc)-Inducible Gene GIG2 Is a Novel
Component of GlcNAc Metabolism in Candida albicans
Swagata Ghosh,a Kongara Hanumantha Rao,a Neel Sarovar Bhavesh,b Gobardhan Das,c Ved Prakash Dwivedi,c Asis Dattaa
National Institute of Plant Genome Research, New Delhi, Indiaa; Structural and Computational Biology Group, International Centre for Genetic Engineering and
Biotechnology (ICGEB), New Delhi, Indiab; Immunology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, Indiac
Candida albicans is an opportunistic fungal pathogen that resides in the human body as a commensal and can turn pathogenic
when the host is immunocompromised. Adaptation of C. albicans to host niche-specific conditions is important for the estab-
lishment of pathogenicity, where the ability of C. albicans to utilize multiple carbon sources provides additional flexibility. One
alternative sugar isN-acetylglucosamine (GlcNAc), which is now established as an important carbon source for many pathogens
and can also act as a signaling molecule. Although GlcNAc catabolism has been well studied in many pathogens, the importance
of several enzymes involved in the formation of metabolic intermediates still remains elusive. In this context, microarray analy-
sis was carried out to investigate the transcriptional responses induced by GlcNAc under different conditions. A novel gene that
was highly upregulated immediately following the GlcNAc catabolic genes was identified and was namedGIG2 (GlcNAc-induced
gene 2). This gene is regulated in a manner distinct from that of the GlcNAc-induced genes described previously in that GlcNAc
metabolism is essential for its induction. Furthermore, this gene is involved in the metabolism ofN-acetylneuraminate (sialic
acid), a molecule equally important for initial host-pathogen recognition. Mutant cells showed a considerable decrease in fungal
burden in mouse kidneys and were hypersensitive to oxidative stress conditions. SinceGIG2 is also present in many other fungal
and enterobacterial genomes, targeted inhibition of its activity would offer insight into the treatment of candidiasis and other
fungal or enterobacterial infections.
The opportunistic fungal pathogen Candida albicans colonizesnumerous niches within the human host (1–3) and causes
infections at mucosal surfaces in the oral cavity and in the gastro-
intestinal and urogenital tracts. During their adaptation to chang-
ing microenvironments, pathogens also encounter the added
challenge of contending with host defenses (4).
For this purpose, C. albicans has evolved specific counterde-
fense strategies, the molecular mechanisms of which are poorly
understood.C. albicans regularly colonizes glucose-poor niches in
the host and thus depends on alternative carbon sources for its
growth (5). N-Acetylglucosamine (GlcNAc) is one such sugar
whose metabolism and linkage with other pathways central to
carbon assimilation or morphopathogenic signaling (6–8) re-
mains understudied, although its utilization pathway is conserved
from pathogenic bacteria to eukaryotes (9).
The enzymes needed to catabolize GlcNAc include Ngt1 (a
transporter that takes up GlcNAc), Hxk1 (a kinase that converts
GlcNAc to GlcNAc-6-phosphate), Dac1 (a deacetylase that con-
verts GlcNAc-6-phosphate to glucosamine-6-phosphate), and
Nag1 (a deaminase that converts glucosamine-6-phosphate to
glucose-6-phosphate) (10–13). For organisms in which GlcNAc
utilization seems to be quite common, the steps involved in the
bifurcation or metabolism (other than the GlcNAc catabolic path-
way) of GlcNAc-6-phosphate, once it is formed, are poorly char-
acterized (14). Our present study, which deals with a gene upregu-
lated in deacetylase and deaminase mutants of C. albicans, sheds
some light on this understudied route emanating from N-acetyl-
glucosamine-6-phosphate, which appears to be a central molecule
for several anabolic and catabolic processes (9, 15). The new
GlcNAc-induced gene GIG2, a DUF1479 family member, has not
been characterized in any organism previously. We characterize
this gene in C. albicans by using multiple experimental ap-
proaches. The GIG2 mutant was sensitive to H2O2 and showed
reduced virulence in a murine model. Affinity purification of the
protein followed by mass spectrometry led to the identification of
N-acetylneuraminate as its substrate. We therefore report that the
GIG2 gene is present in the route where N-acetylneuraminic acid
(Neu5Ac, or NANA) is formed from N-acetylglucosamine-6-
phosphate.
This study thus focuses on an uncharacterized cross talk be-
tween a stress-adaptive mechanism and GlcNAc utilization, and
Gig2 is added to the ever-growing list of virulence factors that
probably contribute to the early events of C. albicans infection.
Though preliminary, our results delineate the pathway where this
GlcNAc-inducible gene, which is well conserved in several entero-
bacterial and fungal pathogens, works; however, the catalytic re-
action of Gig2 for the production of Neu5Ac and the exact role of
this pathway in the attenuation of virulence still remain elusive.
MATERIALS AND METHODS
Media and growth conditions. The standard media YPD (yeast extract-
peptone-dextrose) and SD (synthetic dextrose) (16) were used routinely
for strain growth and maintenance. SN plates were supplemented with
GlcNAc instead of glucose. Selection for URA3 prototrophy and counter-
selection against URA3 were performed as described previously (17). Spi-
der medium at 37°C (16), 2.5 mM GlcNAc in a salt base containing 0.45%
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NaCl, and 0.335% YNB (yeast nitrogen base) without amino acids at 37°C
(18) were used both for colony growth assays and for the induction of
filamentation.
For induction on Spider medium plates, the cells were counted, plated
at a concentration of 40 to 50 cells per plate, and incubated for 5 days at
30°C. For YPD and GlcNAc media, cells were plated similarly and were
incubated at 37°C and 30°C, respectively, for 5 days. Sensitivity to nikko-
mycin Z, Congo red, and calcofluor white was tested by spotting dilutions
of cells onto YPD plates (or onto SD or SN plates for nikkomycin Z)
fortified with the respective chemical. In order to determine the effect of
H2O2, cells were grown in YPD broth for 1 h; H2O2 was added at the
required concentrations (5 and 10 mM); and dilution series were then
spotted onto YPD plates without H2O2.
DNA manipulations. (i) Preparation of the gig2 mutant. The GIG2
(ORF19.4783) deletion mutant was constructed in C. albicans strain
SN152 using the method described previously (19, 20). Precisely, PCR
primers (GIG2-DEL-F and GIG2-DEL-R) were used to amplify either the
LEU2 or theHIS1 selectable marker gene (from plasmid pSN40 or pSN52,
respectively). The integration of the deletion cassettes at the appropriate
sites was verified by performing PCR using combinations of primers that
flanked the integration sites as well as primers that annealed within the
integrated cassettes (CHECK-MUT1, CHECK-LEU2, and CHECK-
HIS1). Complemented strains were constructed by transforming a plas-
mid carrying one wild-type (WT) copy of C. albicans GIG2 (CaGIG2) and
the ARG4 selectable marker gene into the C. albicans genome (primer
CHECK-ARG4 was used for confirmation). The primers and strains used
in this study are listed in Tables S1 and S2 in the supplemental material,
respectively.
(ii) Epitope and GFP tagging. PCR was performed by using plasmid
pGFP-URA3 (21) as the template and appropriate gene-specific primers,
namely, GIG2-GP-F1 and GIG2-UR-R1. The PCR product was used for
the transformation of a C. albicans Ura strain, CAI4. Transformations
were identified by PCRs using one primer that annealed within the trans-
formation module (Tag1) and a second primer that annealed to the target
gene locus outside the altered region (Tag2). The same strain (iGIG2-
GFP) was reconfirmed by Western blot analysis using an antibody against
green fluorescent protein (GFP). Myc-tagged (iHXK1-Myc and iNGT1-
Myc) and hemagglutinin (HA)-tagged (iGIG2-HA) strains were prepared
as described above by using pFA5a-13Myc.URA3 and pFA5a-3HA.URA3
(22), respectively, as the templates.
(iii) TAP tagging. To tandemly tag CaGig2p with the HF (6His and
Flag) epitope in the genomic locus, a DNA fragment containing the 3=
region of GIG2, the 6HF tag sequence, the ACT1 terminator, the URA3
marker, and the downstream region of GIG2 was amplified by using
p6HF-ACT1 (23) as the template and GIG2-HFL-F and GIG2-UR-R1 as
primers, and the amplification product was introduced into CAI4 to gen-
erate iGIG2-HF.
Western blotting. Protein extracts were prepared from C. albicans
cells and were subjected to Western blot analysis as described previously
(24). For detection of the proteins tagged with the HA epitope, mem-
branes were incubated with an anti-HA monoclonal antibody (Roche) at
a dilution of 1:1,000 and a peroxidase-conjugated secondary antibody
(Amersham Biosciences, United Kingdom) at a dilution of 1:20,000. For
detection with an anti-FLAG antibody (Sigma), the dilution was 1:4,000
in 3% skim milk (Difco) in Tris-buffered saline with 0.05% Tween 20
(TBST).
Quantitative real-time PCR. For all reverse-transcription-PCR (RT-
PCR) experiments, total RNA isolated using TriPure isolation reagent was
treated with RNase-free DNase I (Invitrogen) to remove any residual
DNA. About 500 ng of this RNA was used for single-stranded cDNA
synthesis by using a High-Capacity cDNA reverse transcription kit (Ap-
plied Biosystems), and the cDNA was used for quantitative RT-PCR
(qRT-PCR) with SYBR green PCR master mix on an ABI Prism 7000
real-time PCR apparatus (Applied Biosystems). The comparative thresh-
old cycle (CT) method (2
CT) was used to determine relative gene
expression (25). Control reactions without reverse transcriptase were car-
ried out for each cDNA preparation and ascertained that no amplification
was obtained, as judged by high CT values and gel analysis.
Isolation of peritoneal macrophages and fluorescence assay. Mice
(BALB/c) were injected intraperitoneally with 2 ml of 4% thioglycolate
(Brewer Modified; BBL; Becton Dickinson [BD], USA). Five days later,
peritoneal exudates were isolated from the peritoneal cavity by washing
with ice-cold RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS; Thermo Scientific HyClone, USA). Cells were cultured over-
night at 37°C under 5% CO2 and were washed with RPMI medium–10%
FBS to remove nonadherent cells. Adherent monolayer cells were used as
peritoneal macrophages. Peritoneal macrophages (1  105 ml1) were
cultured in RPMI medium and were infected with wild-type C. albicans
and C. albicans mutants at a multiplicity of infection (MOI) of 1:1 for 45
min. Then the cells were washed with fresh RPMI medium twice; fresh
RPMI medium was added to the cells; and the cells were cultured at 37°C
under 5% CO2 for 1 h.
Fluorescence-activated cell sorter (FACS) analysis. For fluorescence,
the cells were washed twice with phosphate-buffered saline (PBS) and
were resuspended in PBS for data acquisition. Fluorescence intensity was
measured by flow cytometry (FACSCanto II; BD), and the data were an-
alyzed with FlowJo (TreeStar, USA).
Mouse infection studies. Animal experiments (with BALB/c mice, 6
to 8 weeks of age) were performed according to the guidelines approved
by the Institutional Animals Ethics Committee of Jawaharlal Nehru
University. Control mice were injected with 100 l PBS as a vehicle control.
Cohorts of 5 mice per C. albicans strain were inoculated for a survival
study. For infection, one colony from each C. albicans strain was inocu-
lated into 50 ml of YPD medium. Cultures were grown overnight, washed
twice with 50 ml of sterile water, counted by hemocytometry, and resus-
pended at 107 cells ml1 in sterile water. Eight- to 9-week-old mice were
injected with 0.3 ml (3 106 cells) of culture or with PBS via the lateral tail
vein, and the course of infection was monitored for as long as 18 days.
Infected mice were considered moribund when they could no longer
reach food or water. Moribund mice, as well as mice surviving to the end
of the experiment, were euthanized by anesthetization followed by cervi-
cal dislocation. In order to assess the fungal burden in kidney tissue, the
dose described above was injected (5 mice per strain per experiment), and
mice were sacrificed at varying time points (24, 42, and 72 h) postinfec-
tion. Kidneys from individual mice (3 to 5 mice per group) were removed
aseptically, weighed, and homogenized in 1 PBS buffer by using a ho-
mogenizer. CFU counts were determined by plating serial dilutions on
YPD agar medium. The colonies were counted after 24 h at 37°C, and
results were expressed as log CFU per gram of tissue. These experiments
were performed three times with 3 to 5 mice per group. For histopatho-
logical studies, kidneys removed 72 h postinfection were fixed in 10%
formaldehyde–PBS, sectioned in paraffin blocks, and stained with peri-
odic acid-Schiff reagent and hematoxylin-eosin (H&E) stain. Examina-
tion was performed under a light microscope, and photographs were
taken with a Nikon camera fitted to the microscope.
Affinity purification andmetabolite extraction.Frozen yeast cell pel-
lets from 500-ml cultures were resuspended in 5 ml lysis solution (200
mM ammonium acetate, 1 Complete protease inhibitor cocktail
[Roche], and 1 mM EGTA). One volume of glass beads (Sigma) was added
to facilitate cell lysis by vortexing for 15 cycles (1 min of vortexing and 1
min of resting on ice), followed by centrifugation at 13,400 g for 30 min.
The supernatants were then subjected to TAP as described by Rao et al. in
2013 (26) with some modifications. In the first round of purification, cell
lysates were incubated with 50 ml of anti-FLAG M2 agarose (Sigma) for
2 h at 4°C, and a second round of purification was performed with
Ni-nitrilotriacetic acid (NTA) agarose (Qiagen) for 1 h at 4°C. The beads
were washed once for 5 min in 300 mM ammonium acetate and once for
5 min in 150 mM ammonium acetate. To extract the protein-bound me-
tabolites (27), 60 ml of pure methanol was added to the beads twice, and
the beads were incubated at room temperature for 10 min. The methanol
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extract was then immediately transferred to a Waters Max Recovery glass
vial and was analyzed by mass spectrometry. The beads were then boiled
in 50 ml of 1 SDS sample buffer for 5 min, and 15 ml of the supernatant
was resolved on a 12% SDS-PAGE gel, followed by a silver staining reagent
(Bio-Rad).
UPLC-coupled ESI mass spectrometry. The mass spectrometry sys-
tem used in this study comprised an Acquity ultraperformance liquid
chromatograph (UPLC) system and a Synapt G2 mass spectrometer
equipped with an electrospray ionization (ESI) probe (Waters Co., Mil-
ford, MA). For each run, 10 l metabolite extract was loaded onto a C18
column using a binary solvent gradient of 5% to 95% methanol in water
for 12 min and 95% methanol for another 5 min. The collection mass
range was 100 to 1,200 m/z in profile scan mode to avoid missing uncom-
mon mass adducts. The probe and source temperatures were 500°C and
130°C, respectively. The data were processed though MarkerLynx soft-
ware, version 4.1 (Waters Co., Milford, MA) (27).
NMR spectroscopy. Wild-type and gig2 and dac1 (14) mutant strains
were selected for nuclear magnetic resonance (NMR) analysis of metab-
olites. Exponentially grown cells in SD medium were collected, washed
twice, and induced in SN medium (with a stable isotope ofN-acetyl-D-[1-
13C]glucosamine) for 2 h. The metabolites were extracted as described by
Yu et al. in 2013 (28). The dried sample was dissolved in 200 l D2O and
was used for measuring NMR spectra.
Two-dimensional (2D) 13C,1H heteronuclear single quantum coher-
ence (HSQC) spectra were measured at 25°C on a Bruker Avance III
spectrometer equipped with a cryogenic triple-resonance TCI probe head,
operating at a field strength of 500 MHz. Temperature calibration was
performed using a 100% d4-methanol sample (29). All spectra were ac-
quired and processed with TopSpin, version 2.1 (Bruker AG). All data
were analyzed using CARA (30). Standard 2D 13C,1H HSQC spectra and
peak lists deposited in the Biological Magnetic Resonance Data Bank
(BMRB) (http://www.bmrb.wisc.edu/; accession no. bmse000231,
bmse000163, bmse000205, and bmse000057) and the Human Metabo-
lome Database (HDMB) (http://www.hmdb.ca/; HMDB identification
no. HMDB00290, HMDB00803, and HMDB00230) were used for the
identification of resonance peaks.
RESULTS
GIG2 induction is specific to GlcNAc. Comparative microarray
analysis of glucose versus GlcNAc and of glycerol versus GlcNAc
showed ORF19.4783 to be a prominently induced gene; the level
of induction was 28-fold for GlcNAc versus glucose and 22-
fold for GlcNAc versus glycerol. Interestingly, this gene showed
downregulation in an hxk1 mutant in response to GlcNAc (Fig.
1A). Western blot analysis with a strain in which this gene was
C-terminally tagged with a 3HA tag revealed that its expres-
sion is specific only for GlcNAc and not for other sugars, such
as N-acetylmannosamine (ManNAc), N-acetylgalactosamine
(GalNAc), galactose, and glucose, or for nonfermentable car-
bon sources, such as glycerol, lactate, acetate, citrate, and eth-
anol (Fig. 1B).
ORF19.4783 turned out to be a conserved hypothetical protein
of 474 amino acids and a member of the DUF1479 family. We
named it GIG2 (GlcNAc-induced gene) in accordance with the
nameGIG1 reported by Gunasekera et al. in 2010 (31). For protein
localization data, we chromosomally tagged GIG2 at the C-termi-
nal region with a GFP sequence (21). The Gig2-GFP fusion pro-
tein localized to the cytoplasm in the presence of 2% GlcNAc (Fig.
1C). This further confirmed that this gene is induced by GlcNAc
and that the corresponding functional protein is one of the pro-
teins linked to GlcNAc metabolism. Our study provides the first
evidence that at least one member of the DUF1479 family shows
protein expression specific to GlcNAc and localizes in the cyto-
plasm. Strains iGIG2-GFP and iGIG2-HA were checked for func-
tionality by their abilities to complement the growth defects
shown by the gig2 mutant strain in the presence of H2O2 (see Fig.
S1 in the supplemental material).
GlcNAc catabolism is required for GlcNAc-specific induc-
tion of GIG2. Previous studies (14, 26) have indicated that
GlcNAc directly induces GlcNAc catabolic gene expression irre-
spective of GlcNAc catabolism. In addition to direct induction by
GlcNAc, metabolic intermediates arising out of catabolism can
also regulate gene expression in the overall process of GlcNAc
metabolism. These facts were clear from expression analysis of an
hxk1 mutant compared with the wild type in response to GlcNAc
(Fig. 1A; see also Fig. S2 in the supplemental material). Further, we
carried out real-time RT-PCR analysis in order to understand the
expression patterns of GIG2 and other GlcNAc-inducible genes in
wild-type C. albicans and catabolic pathway mutants in the pres-
ence of GlcNAc. Surprisingly,GIG2was downregulated 12-fold in
the hxk1 mutant, whereas NAG1 and GAL10 expression levels
were unaltered (Fig. 1A and D). Then we checked for the expres-
sion of GIG2 in the dac1and nag1 mutant backgrounds and found
the gene to be upregulated at least 2-fold compared to expression
in GlcNAc-grown wild-type cells (Fig. 1D). We hypothesized that
the downregulation of GIG2 in the hxk1 mutant could be due to
the inability of the hxk1 mutant to form GlcNAc-6-phosphate.
Otherwise stated, GlcNAc catabolism or, more specifically,
GlcNAc-6-phosphate, an intermediary product of GlcNAc ca-
tabolism, seemed to be essential for the induction of this gene.
Thus, Gig2 probably acts at a point downstream of Hxk1 and
upstream of Dac1 and Nag1, at a place where GlcNAc-6-phos-
phate diverges to other anabolic pathways. This interesting ob-
servation provided clues for understanding the poorly studied
biochemical pathways in C. albicans emanating from GlcNAc-6-
phosphate, which are probably conserved among pathogenic
fungi and enterobacterial species.
Gig2 protein is induced late. Western blot analysis was per-
formed for protein extracts obtained from cells (iGIG2-HA) in-
duced and collected at different time points. Gig2 was detectable
at least after 30 min of induction and reached peak levels at 120 to
180 min of induction (Fig. 1E, top), whereas the GlcNAc catabolic
enzymes Ngt1 and Hxk1 reached maximum levels within 30 and
60 min of induction, respectively (Fig. 1E, bottom) (10). This late
induction of Gig2 could be due to a secondary response of the cell
to GlcNAc, where a probable increase in the pool of GlcNAc-6-
phosphate initiates other pathways (of which Gig2 may be a mem-
ber) diverging from this intermediary metabolite. The probable
significance of late induction is discussed below.
The gig2 mutant exhibited reduced filamentation under
some inducing conditions and showed uncompromised growth
on GlcNAc. Since dimorphism is a long-suspected mechanism of
virulence (13, 32), we investigated the effect of disruption ofGIG2
on the colony morphology of C. albicans on plates containing
established media such as YPD (37°C), Spider, and GlcNAc me-
dia. Hyphal formation by homozygous mutants was impaired to
some extent under all of the conditions mentioned above, and
these mutants were mostly smooth at the periphery (Fig. 2A).
Interestingly, after 5 days, 35% of colonies in YPD medium at
37°C showed a sectored morphology with distinct white and
opaque regions; the reasons for this phenomenon are not known.
The ability of the gig2 mutant strain to grow on GlcNAc was also
checked by spotting serial dilutions of cells onto a solid agar me-
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dium containing either GlcNAc or dextrose as the carbon source.
No difference in the growth rate was observed (Fig. 2B). Thus,
GIG2 is not needed for normal growth on GlcNAc plates but con-
tributes to some extent toward filament formation under hypha-
inducing conditions.
The gig2 mutant showed sensitivity to hydrogen peroxide.
Our results show that GIG2 is not involved in the main GlcNAc
catabolic cascade and is induced late upon GlcNAc addition. We
presumed this gene to be a member of the secondary metabolic
pathways arising out of GlcNAc-6-phosphate that could be instru-
mental in combating stress responses. Therefore, we checked the
sensitivities of the mutant and wild-type strains to a range of
stress-inducing agents. Notably, deletion of GIG2 specifically re-
sulted in impaired resistance to the oxidative-stress-inducing
agent H2O2 (Fig. 2C) at low concentrations (5 and 10 mM). In
contrast, no notable increase in sensitivity to other oxidative-
stress-inducing agents, such as Na3N (an inhibitor of complex
III), or to cell wall biogenesis inhibitors, such as calcofluor white
and Congo red, was observed. Similarly, no marked difference
could be observed in the mutants when they were grown in the
presence of the chitin synthase inhibitor nikkomycin Z (Fig. 2D).
Gig2-GFP is induced by macrophage phagocytosis. Previous
reports have shown that C. albicans has evolved mechanisms to
induce the utilization of carbon sources other than glucose upon
engulfment by macrophages, probably to facilitate the utilization
of host-derived macromolecules, and, furthermore, that the inter-
action ofC. albicanswith macrophages is considered a crucial step
in the development of an adequate immune response in systemic
candidiasis (33). Interestingly, Gig2-GFP was induced after
phagocytosis by primary murine macrophages in three indepen-
FIG 1 GlcNAc-specific expression of GIG2. (A) Heat map showing the ratio of differential expression of GIG2 in response to GlcNAc under four different
conditions. The average expression values obtained from two biological replicates with dye swap were used. The color scale at the bottom indicates the log2 ratio.
(B) Gig2-HA is specifically induced by GlcNAc. The untagged control strain CAF2-1 or the HA-tagged strain iGIG2-HA was grown in a synthetic medium
containing the indicated sugars (2% each) for 3 h. Western blotting was performed with an anti-HA antibody. Ponceau-stained bands are shown as a loading
control. (C) Gig2 localizes to the cytoplasm. The wild-type untagged control strain CAF2-1 or the GIG2-GFP strain iGIG2-GFP was grown in a synthetic medium
containing 2% GlcNAc for 3 h and was visualized by confocal microscopy. The central panel shows a merged view of cells under GFP and 4=,6-diamidino-2-
phenylindole (DAPI) filters. (D) Relative expression of GlcNAc-inducible gene transcripts in wild-type C. albicans (CAF2-1) and in GlcNAc catabolic pathway
mutants (hxk1, dac1, and nag1 mutants). ACT1 (encoding actin) was used as the endogenous control. All experiments were performed with two biological
replicates; each sample was loaded in triplicate for qPCR. Error bars represent coefficients of variation. (E) Time kinetics for the expression of Gig2 protein and
of the GlcNAc catabolic proteins Ngt1 and Hxk1. Shown is the expression of Gig2 (top), Ngt1, and Hxk1 (bottom) after the addition of GlcNAc. Cell extracts from
different strains at different time points (as indicated) were analyzed by Western blotting and were probed with an anti-HA or anti-c-Myc antibody.
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dent experiments, and there was some nonspecific fluorescence in
macrophages that had phagocytosed untagged wild-type cells. The
level of Gig2-GFP was readily detected above this background.
FACS analysis with the iGIG2-GFP strain (5-fold increase in ex-
pression over that of untagged infected cells) also supported the
epifluorescence observation (see Fig. S3A and B in the supplemen-
tal material). Thus,GIG2 is induced upon phagocytosis along with
other GlcNAc catabolic genes, such as NGT1 (13).
The gig2 mutant showed decreased virulence. We investi-
gated the impact ofGIG2deletion during mammalian infection by
using the mouse model of hematogenously disseminated candidi-
asis. When the homozygous mutant was used, none of the mice
died until day 9, and almost 85% of the mice were alive at the end
of day 11—the time by which all the mice infected with the wild
type C. albicans strain had died. The virulence of the revertant was
less than that of the wild-type strain, and 25% of the mice were
alive at the end of day 11 (Fig. 3A).
Since kidneys are considered to be the organs preferentially
FIG 2 Morphogenesis and growth analysis of gig2 mutant cells. (A) The gig2 mutant showed reduced filamentation on YPD and Spider media (37°C) and on SN
medium (30°C) under the conditions indicated. (B) The gig2 mutant showed unaltered growth on GlcNAc plates. Tenfold dilution series of the indicated C.
albicans strains were spotted onto synthetic medium agar plates containing either glucose or GlcNAc at 2%. (C) Response of the gig2 mutant to hydrogen
peroxide. For H2O2 stress, wild-type, gig2 mutant, and revertant strains were grown and either left untreated (top) or treated with 5 mM (center) or 10 mM
(bottom) H2O2. The untreated and treated cells were spotted onto YPD plates and were incubated at 30°C for 2 days. (D) Response of the gig2 mutant to
nikkomycin Z. Strains were grown in YPD medium for 8 h at 30°C, and 10-fold dilution series were spotted onto plates containing either SD medium alone, SD
medium plus nikkomycin Z (20 g ml1), or SN medium plus nikkomycin Z (20 g ml1).
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colonized by C. albicans, one kidney from each mouse (5 mice/
strain) was recovered 3 days postinfection and was preserved for
histopathological studies. Before fixation, the entire surface of the
kidney was photographed in order to determine the severity of
lesion/abscess formation with each strain. A kidney from a PBS-
injected mouse was used as a control. Numerous fungal abscesses
were found with wild-type C. albicans, much fewer with the ho-
mozygous mutant, and none for PBS-injected mice (Fig. 3B). His-
tological sections of kidney recovered from wild-type-infected
mice and stained with periodic acid–Schiff stain revealed huge and
numerous focal collections ofCandidafilaments, whereas sections
from the mutant showed very few areas of infection (Fig. 3C). The
kidney sections of wild-type-infected mice also showed damage to
almost the entire cortical region due to large necrotic areas and the
sloughing of tubular epithelial cells into the lumen. With the mu-
tant strain, the tubular space was almost free of such depositions
(Fig. 3D). These observations also suggest that the severity of or-
gan damage by the pathogen was reduced in the gig2 mutant.
To evaluate whether the reduced virulence of the gig2 strain
was due to its reduced multiplication in vivo, we conducted a
parallel set of experiments in which mice infected with either the
WT or the mutant were sacrificed, and the level of fungal coloni-
zation of the kidney, one of the major target organs in systemic
candidiasis, was determined. High fungal burdens were observed
in WT-infected mice from 24 h to 72 h after the initiation of
infection. CFU counts from the kidneys of mice infected with the
gig2 strain were significantly lower than those for WT-infected
mice (Fig. 3E).
Identification of Gig2-interacting metabolites. To identify
small metabolites bound to Gig2 protein, we used affinity protein
purification coupled with mass spectrometry (27). Then bound
metabolites were extracted in methanol from a purified protein-
metabolite complex (Fig. 4A), and protein purity was examined
using SDS gel electrophoresis after metabolite extraction (Fig.
4B). N-Glycolylneuraminate was identified as the metabolite in-
teracting with Gig2 (Fig. 4C and D). However,N-glycolylneuram-
inate does not occur in Candida albicans (34). Hence, we con-
cluded that the compound would be N-acetylneuraminate that
had undergone oxidation during experimental procedures to
yield N-glycolylneuraminate.
NMR analysis. Solution-state NMR spectroscopy was used to
trace the catabolic route of N-acetylglucosamine-6-phosphate
when the normal catabolic pathway is blocked, as in the case of the
deacetylase (dac1) mutant. For this purpose, the three strains ofC.
albicans (the wild type and the dac1 and gig2mutants) were grown
in the presence of 1-13C-labeled N-acetyl-D-glucosamine and/or
glycerol. Glycerol was added to act as a carbon source, since the
FIG 3 GIG2 deficiency results in decreased virulence. (A) Infection of mice
with the gig2 mutant leads to enhanced survival. Mice were infected intrave-
nously with 3 106 cells of the WT (CAF2-1), mutant, or revertant strain. The
experiment was performed with 6 mice and was repeated three times. The
percentage of mice surviving is given along the y axis, and the number of days
after infection is given along the x axis. (B) Kidney surface views showing the
severity of abscess formation. Abscesses (white pustules, indicated by black
arrows) are more numerous in kidneys infected with the wild type (CAF2-1)
than in gig2 mutant-infected kidneys. (C) Periodic acid-Schiff staining of
kidney sections from mice infected with the wild type or the gig2mutant 3 days
after intravenous injection. As a control, mice were injected with PBS. Pictures
were taken at magnifications of 20 (top) and 40 (bottom). The lower
panels show magnifications of the boxed areas in the upper panels. Arrows
point to filaments within the tissue. (D) Tubular casts and sloughing of the
tubular cells, indicated by arrows. In mice given the mutant strain or PBS, the
tubular space was almost clean. The experiments were performed in triplicate.
(E) Subgroups of 3 to 5 mice were sacrificed at 24, 48, or 72 h after infection.
The quantitative fungal burden in the kidney was measured by serial dilution
and is expressed as log CFU per gram of tissue (y axis). Data in panels A and E
are presented as means  standard errors of the means from three separate
experiments (P,0.01).
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deacetylase mutant would be unable to utilize GlcNAc. The aque-
ous extract of the lysed culture was subjected to solution-state
NMR spectroscopy. In the 2D 13C,1H HSQC spectrum of the
aqueous extract of the dac1 culture, we observed very strong res-
onance signals of 10-13C-labeled N-acetyl-D-glucosamine-6-
phosphate, 2-13C-labeled N-acetyl-D-glucosamine-1-phosphate,
and 1-13C-labeled UDP-N-acetyl-D-glucosamine in addition to
both 	 and 
 anomers of [1-13C]GlcNAc (Fig. 5A). The 13C label-
ing of the C-10, C-2, and C-1 carbons of GlcNAc-6-phosphate,
GlcNAc-1-phosphate, and UDP-GlcNAc, respectively, confirms
the pathway bifurcation once GlcNAc-6-PO4 is unable to be ca-
tabolized further. Due to the high sensitivity of the cryoprobe, we
also observed the weak resonance peaks of other carbons at their
natural 13C abundances in the 2D 13C,1H HSQC spectrum (Fig.
5B). Interestingly, we also observed a very weak resonance of
2-13C-labeled N-acetylneuraminic acid (Fig. 5B). From the spec-
trum, it is very clear that the concentration ofN-acetylneuraminic
acid is much (100-fold) lower than those of other metabolites,
such as GlcNAc-6-phosphate, GlcNAc-1-phosphate, and UDP-
GlcNAc. This confirms that the dac1 mutant predominantly uses
the pathway that leads to the formation of UDP-GlcNAc and also
enters the N-acetylneuraminic acid metabolic pathway, albeit at a
low rate.
A spectral comparison of the WT and the gig2mutant (Fig. 5C)
showed that 1-13C-labeled N-acetyl-D-glucosamine is completely
catabolized in both strains and is used as a carbon source. A strik-
ing observation was that no resonance ofN-acetylneuraminic acid
could be found in the gig2 mutant.
DISCUSSION
A member of the DUF1479 family of proteins. The unexplored
sectors of the protein universe appear to have been shaped primar-
ily by extreme diversification of known protein families, which
then enabled organisms to evolve new functions and adapt to
particular niches and habitats. Such unexplored proteins are often
described as “hypothetical” but are bona fide proteins that have
FIG 4 Identification of small metabolites associated with Gig2 protein. (A) Chart demonstrating the work flow for the identification of the metabolite bound to
protein. (B) After two rounds of purification and extraction in methanol, the beads were boiled and were resolved on SDS-PAGE to check for the presence of
purified Gig2. (C) LC plots of the small metabolites extracted from a protein (Gig2) (green) and the negative control (untagged) (red). Peak intensity is plotted
against the retention times (in minutes) of corresponding mass spectra. All traces were smoothed by the Savitzky-Golay method using two passes with a window
size of three scans. (D) Combined average mass spectra of the 9.02- to 10.020-min region. The mass of the Gig2-bound small metabolite is given along with its
chemical identity. The peak mass (in atomic mass units) is shown along the x axis and the peak intensity (expressed as a percentage) along the y axis.
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not yet been the focus of any detailed study. The PFAM database
currently contains more than 2,200 such families, referred to as
domains of unknown function (DUF) (35). ORF19.4783 was one
such protein that showed the highest upregulation immediately
after the set of GlcNAc catabolic genes. Like another novel
GlcNAc-induced gene,GIG1, recently described by Gunasekera et
al. (2010) (31), GIG2 also resides on chromosome 1 and is not
linked to the cluster of GlcNAc catabolic genes (HXK1,NAG1, and
DAC1) on chromosome 6 or to the GlcNAc transporter NGT1 on
chromosome 3. Further, its mode of regulation also seems to be
different from those of GlcNAc catabolic genes, such as NGT1,
HXK1, NAG1, and DAC1, that are directly induced by GlcNAc.
GIG2, in contrast, is induced in response to the GlcNAc catabolic
intermediate GlcNAc-6-PO4. This is clear from real-time RT-PCR
analysis (Fig. 1D) and is supported by data from comparative
expression profiles of some GlcNAc-inducible genes (see Fig. S2 in
the supplemental material), showing the downregulation of a few
genes, such as Orf19.4737 (DHA12) and Orf19.3392, along with
GIG2, in the hxk1 mutant in response to GlcNAc relative to ex-
pression in the wild type.
Gig2 is a member of the DUF1479 family in C. albicans, which
shares its closest homology with a member of the enterobacteria
(Protein Data Bank [PDB] identification [ID] code 2CSG). Jaro-
szewski et al. (2009) (35), in their in silico analysis based on remote
homology, predicted that Gig2 was a putative oxidoreductase. A
BLAST search (36) withC. albicansGig2 revealed the conservation
of this protein among various metazoans, plant, some fungal
pathogens, and members of the Enterobacteriaceae, but it was ab-
sent in humans (see Fig. S4 in the supplemental material). The
occurrence of Gig2 could not always be correlated with the occur-
rence of the GlcNAc catabolic genes. Probably, the presence of
Gig2 homologues provides a competitive advantage for fungal
pathogens and enterobacteria, enabling them to survive under
niche-specific conditions, and contributes to their pathogenicity.
Its occurrence in plants and metazoans could serve other, yet to be
discovered purposes.
A novel pathway associated with N-acetylglucosamine me-
tabolism in Candida albicans. Our qRT-PCR analysis for the
relative expression of GIG2 in hxk1, dac1, and nag1 mutants indi-
cated that Gig2 acts on a pathway downstream of the formation of
GlcNAc-6-phosphate and branching at a point before the action
of the deacetylase and deaminase genes of the GlcNAc catabolic
pathway. Although reports on the formation of UDP-GlcNAc
from GlcNAc-6-phosphate in C. albicans are available, nothing is
known about the probable pathway that governs the formation of
NANA (N-acetylneuraminic acid) from GlcNAc-6-phosphate.
The occurrence of NANA has been reported in many cases and has
been shown to modulate cell interactions and carbohydrate-de-
pendent physiological or pathophysiological responses (37).
Therefore, in a glucose-poor environment, where GlcNAc could
predominate as a carbon source, GlcNAc-6-phosphate could be
converted to NANA via a route that has been reported in humans.
NMR spectroscopy data with a GlcNAc-6-phosphate deacety-
lase mutant (where GlcNAc-6-phosphate could no longer be
deacetylated and deamidated to be fed into the glycolytic path-
way) showed a great preponderance of three molecules: GlcNAc
6-phosphate, GlcNAc-1-phosphate, and UDP-GlcNAc (Fig. 5A).
All three of these molecules fall in the more thermodynamically
favored first route (GlcNAc-6-phosphate ¡ GlcNAc-1-phos-
phate¡UDP-GlcNAc) of GlcNAc-6-phosphate catabolism once
the normal glycolytic entry is blocked.N-Acetylneuraminic acid, a
form of sialic acid, was also detected, albeit at low levels (Fig. 5B).
Our data with the gig2 mutant grown in the presence of nikkomy-
cin Z (which acts on chitin synthase and competes for UDP-
GlcNAc) showed no difference from wild-type cells. Had Gig2
been involved anywhere in this route of UDP-GlcNAc formation,
a mutation in this gene would have affected this route, with obvi-
ous growth defects in the presence of nikkomycin Z. Under such
circumstances, we presumed that Gig2 could be involved some-
where in the second route, probably emanating from GlcNAc-6-
phosphate, that ultimately leads to the formation of NANA. The
absence of an N-acetylneuraminic acid spectrum in NMR con-
ducted with the gig2 mutant lent credence to this hypothesis (Fig.
5C). Affinity purification coupled to mass spectrometric analysis
for the study of the protein-metabolite interaction yielded N-gly-
colylneuraminic acid, which is an oxidized form of N-acetyl-
neuraminic acid. We concluded that this molecule, in fact, could
be N-acetylneuraminic acid, which during ESI or other experi-
mental procedures probably underwent oxidation to yield N-gly-
colylneuraminic acid. This result strengthened our earlier pre-
sumption that Gig2 probably works in the route that ultimately
leads to the metabolism of N-acetylneuraminic acid via GlcNAc-
6-phosphate.
In humans, the pathways leading to the synthesis of N-acetyl-
neuraminic acid (sialic acid) have been characterized. The first
committed intermediate in the biosynthesis of sialic acid is N-
acetylmannosamine (ManNAc), which is phosphorylated by
ManNAc-6-kinase (38, 39) to initiate sialic acid biosynthesis in
the cytosol. In principle, N-acetylmannosamine can be produced
in the cell through one of two possible routes: (i) by UDP-N-
acetylglucosamine (UDP-GlcNAc) 2-epimerase, which catalyzes
the conversion of UDP-GlcNAc to ManNAc, or (ii) by GlcNAc-
2-epimerase, which can produce ManNAc by catalyzing the re-
versible epimerization of GlcNAc to ManNAc. Studies suggest
that the formation of ManNAc via the second route is negligible
under physiological conditions, since GlcNAc is thermodynami-
cally favored with an equilibrium ratio of almost 4:1. Thus,
GlcNAc-2-epimerase has been postulated to divert ManNAc away
FIG 5 NMR analysis of pooled metabolites in the dac1 mutant. (A) Selected regions of a 2D 13C,1H HSQC spectrum of an aqueous extract of the dac1 mutant
showing strong resonance peaks of 10-13C-labeled N-acetyl-D-glucosamine-6-phosphate, 2-13C-labeled N-acetyl-D-glucosamine-1-phosphate, and 1-13C-la-
beled UDP-N-acetyl-D-glucosamine, in addition to both	 and
 anomers of 1-13C-labeledN-acetyl-D-glucosamine. (B) Weak resonance signals of other carbons
of GlcNAc (peaks a to l), GlcNAc-6-phosphate (peaks a to c, h, j, k, m to p, and z), and GlcNAc-1-phosphate (peaks a, d to f, h to i, and z) at the natural abundance
of 13C. The resonance peak of 2-13C-labeled N-acetylneuraminic acid is marked. Peaks x and y could not be identified. The spectrum was acquired at 25°C on
aqueous extracts with 8 scans per t1 increment in the
13C dimension on a 500-MHz NMR spectrometer equipped with a cryogenic 5-mm TCI probe head.
Acquisition times for the 13C and 1H dimensions were 2.5 ms (t1max) and 146.2 ms (t2max), respectively. Spectral widths for the
13C and 1H dimensions were
25,155.08 Hz and 7,002.8 Hz, respectively. (C) Overlapped selected regions of 2D 13C,1H HSQC spectra of aqueous extracts of the wild type (red) and the gig2
(blue) and dac1 (black) mutants. The resonance signal of 2-13C-labeled N-acetylneuraminic acid is boxed in green. 2-13C-labeled N-acetylneuraminic acid is not
found in the gig2 mutant.
Ghosh et al.
74 ec.asm.org Eukaryotic Cell
 o
n
 M
arch 14, 2018 by guest
http://ec.asm
.org/
D
ow
nloaded from
 
from sialic acid biosynthesis and into other glycolytic pathways
(40). But under conditions of stress, such as those encountered
when a pathogen evades host immune responses to establish in-
fection, this equilibrium ratio might be altered so that the produc-
tion of NANA is favored over that of GlcNAc-6-phosphate/UDP-
GlcNAc. This hypothesis seems rational when one considers the
importance of surface molecules of fungal cells in vivo. Future
work aimed at delineating the exact reaction that Gig2 catalyzes,
along with the metabolic profiling of the subsidiary pathways
branching from GlcNAc-6-phosphate, would improve our under-
standing of the importance of intermediate products of GlcNAc
metabolism.
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